Literature DB >> 15389726

Explaining racial differences in prostate cancer in the United States: sociology or biology?

Stephen J Freedland1, William B Isaacs.   

Abstract

Black men in the United States have the highest incidence and mortality from prostate cancer in the world. Even after adjusting for stage at diagnosis, black men have higher mortality rates than white men. Multiple reasons have been postulated to explain these findings including access to care, attitudes about care, socioeconomic and education differences, differences in type and aggressiveness of treatment, dietary, and genetic differences. While each reason may contribute to the higher incidence or higher mortality, likely combinations of reasons will best explain all the findings. Racial differences in socioeconomic status have been well established and we review the significance of these findings in relationship to prostate cancer. Also, with recent advances in the understanding of genetic variation in the human genome, in general, and in the genes involved in pathways relevant to prostate cancer biology, in particular, a number of genes with alleles which differ in frequency between black and white men have been proposed as a genetic cause or contributor to the increased prostate cancer risk in black men. However, the clinical significance of these genetic differences is not fully known. Finally, we conclude with some thoughts as to how to integrate the findings from sociological as well as biological studies and touch upon methods to reduce the disparate burden of prostate cancer among blacks in the United States. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15389726     DOI: 10.1002/pros.20052

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  56 in total

1.  Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.

Authors:  Lindsey Enewold; Jing Zhou; Katherine A McGlynn; Susan S Devesa; Craig D Shriver; John F Potter; Shelia H Zahm; Kangmin Zhu
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

2.  African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Authors:  Augustine C Obirieze; Ambria Moten; Delenya Allen; Chiledum A Ahaghotu
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-16

3.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma.

Authors:  Mario Mandalà; Gian Lorenzo Imberti; Dario Piazzalunga; Maurizio Belfiglio; Giuseppe Lucisano; Roberto Labianca; Lorenzo Marchesi; Barbara Merelli; Silvana Robone; Paola Poletti; Laura Milesi; Carlo Tondini
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

Review 5.  Admixture mapping as a tool in gene discovery.

Authors:  Michael F Seldin
Journal:  Curr Opin Genet Dev       Date:  2007-04-26       Impact factor: 5.578

6.  Disparities in oncologic surgery.

Authors:  Caprice C Greenberg; Jane C Weeks; Steven C Stain
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

7.  Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Authors:  Susan Halabi; Sandipan Dutta; Catherine M Tangen; Mark Rosenthal; Daniel P Petrylak; Ian M Thompson; Kim N Chi; John C Araujo; Christopher Logothetis; David I Quinn; Karim Fizazi; Michael J Morris; Mario A Eisenberger; Daniel J George; Johann S De Bono; Celestia S Higano; Ian F Tannock; Eric J Small; William Kevin Kelly
Journal:  J Clin Oncol       Date:  2018-12-21       Impact factor: 44.544

8.  MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.

Authors:  Li Zhang; Jianghua Wang; Yongquan Wang; Yiqun Zhang; Patricia Castro; Longjiang Shao; Arun Sreekumar; Nagireddy Putluri; Nilanjan Guha; Saligrama Deepak; Arunkumar Padmanaban; Chad J Creighton; Michael Ittmann
Journal:  Cancer Res       Date:  2016-08-30       Impact factor: 12.701

9.  Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.

Authors:  Eric J Whitman; Mark Pomerantz; Yongmei Chen; Michael M Chamberlin; Bungo Furusato; Chunling Gao; Amina Ali; Lakshmi Ravindranath; Albert Dobi; Isabell A Sesterhenn; Isabell A Sestrehenn; David G McLeod; Shiv Srivastava; Matthew Freedman; Gyorgy Petrovics
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

10.  Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Michelle Jankowski; Sheri Trudeau; Andrew Rundle; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2012-10-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.